all about terminal illnesses
← All diseases Liver, kidneys and digestion

Short bowel syndrome

Would you like to receive a message when there is new research on Short Bowel Syndrome? This is possible with an account. Create a free account or log in.

Last updated: 2026-08-10 · automatically checked, spot-checked

# Treatment methods for short bowel syndrome

The goal of treatment for short bowel syndrome (SBS) is to absorb as many nutrients as possible through the intestines, maintain body function, prevent complications, and improve quality of life. The approach is stepwise: first, attempts are made to manage with adapted diet and supportive therapies, and only when that is insufficient, medications or more intensive forms of nutrition are introduced.

Nutritional therapy and nutrition via infusion

The first step in treatment is usually adjusting what and how you eat. A gastroenterologist and dietitian help establish a nutrition plan that matches how much intestine you have and how well it functions. Often, many small meals are given instead of three large ones, so the remaining intestine can absorb better. The type of food is also considered: for example, some people tolerate liquid nutrition better than solid food, and others benefit from nutrition that contains less fat.

ProveniIncluded in official guidelines, or approved by EMA or FDA

When the small intestine does not absorb enough nutrients, nutrition via infusion (total parenteral nutrition, TPN) may be necessary. This is a liquid nutrition delivered directly into a blood vessel, so the body can use it without it having to pass through the intestines. This can be done at home, often in the evening. This provides much freedom during the day, but requires learning to manage the infusion line properly and regular medical supervision. Side effects can occur around the infusion site (infection, blockage) or in the longer term with the liver.

ProveniIncluded in official guidelines, or approved by EMA or FDA

Medications that stimulate the intestines

Medications from the group of GLP-1 analogues can help the remaining intestine function better. They stimulate the intestine to absorb more nutrients and can improve the passage of nutrition through the intestines. These agents come from research into diabetes and obesity, but are also being investigated for short bowel syndrome. They are injected under the skin. Side effects can include nausea, abdominal pain, and changes in gastric emptying.

ResearchediPositive results in clinical studies, not yet standard treatment

Another agent being investigated is glepaglutide. It works similarly to GLP-1 analogues and appears to increase nutrient absorption and improve intestinal function. It is not yet available in all countries outside of trials.

ResearchediPositive results in clinical studies, not yet standard treatment

Support of intestinal function

Some medications help keep the intestines more moist, so nutrition stays in contact with the intestinal mucosa longer and can be absorbed better. This may be relevant for people with significant diarrhea. Agents can also be used that slow the passage of nutrition through the intestines, allowing more time for absorption.

ProveniIncluded in official guidelines, or approved by EMA or FDA

Microbiome support

Research shows that the composition of bacteria in the intestines (the microbiome) is important for nutrient absorption and health. In short bowel syndrome, this microbiome is often dysregulated. Dietitians can advise on food choices that encourage certain beneficial bacteria. It is also being investigated whether nutrients (prebiotics) or bacterial preparations (probiotics) can help, but evidence for this is still limited and the effect varies greatly between individuals.

ResearchediPositive results in clinical studies, not yet standard treatment

Treatment of complications

Prevention of blood clots

Because people with short bowel syndrome receive long-term nutrition via infusion through a blood vessel, there is an increased risk of blood clots around the infusion line. An ESPEN guideline (European nutrition organization) from 2026 recommends regular medical supervision and, where necessary, medications that slow blood clotting. These are the same agents used in other conditions with clotting risk.

ProveniIncluded in official guidelines, or approved by EMA or FDA

Protection of the liver

Long-term total parenteral nutrition can eventually strain the liver (intestinal failure-associated liver disease). Medical monitoring includes regular blood tests. Certain nutritional adjustments can also help, such as adding specific fats or continuing to use as much normal food by mouth as possible, even if this covers only a small part of nutritional needs.

ProveniIncluded in official guidelines, or approved by EMA or FDA

Treatment of high output stoma

Some people have an artificial opening (stoma) after bowel surgery or experience severe diarrhea with significant fluid loss. New research from 2026 shows that certain medications (GLP-1 analogues) can help reduce this fluid loss and stabilize fluid balance.

ResearchediPositive results in clinical studies, not yet standard treatment

Bowel regeneration and surgical options

Bowel lengthening and surgery

In some cases, surgical procedures can help. For example, by freeing up the remaining bowel and stretching it longer, or by restoring blood supply to bowel segments that no longer receive it (revascularization). These are complex procedures that only take place in specialized centers. Recent research shows that a combination of bowel resection (removal of damaged segments) and vascular repair can be beneficial for certain patients.

ProveniIncluded in official guidelines, or approved by EMA or FDA
(in selected cases)

Bowel tissue regeneration

Research into whether damaged bowel can regenerate or 'regrow' is ongoing. This includes the use of growth factors and stem cells, but these treatments are still in the research and experimental phase and are not routinely available.

ExperimentaliOngoing in study setting, outcome still unknown

Supportive Treatment

RELiZORB

This is an investigational product that helps break down protein in the small intestine so it can be better absorbed. A phase 3 trial is underway in 2026. It has not yet been accepted as standard treatment.

ResearchediPositive results in clinical studies, not yet standard treatment

Regular medical monitoring

Because short bowel syndrome can have many consequences (fluid deficiency, mineral deficiencies, liver strain, infections), regular contact with the hospital is important. This includes blood tests, monitoring of weight and dehydration, and discussions about nutrition and quality of life.

ProveniIncluded in official guidelines, or approved by EMA or FDA

Psychosocial support

Living with short bowel syndrome can be emotionally burdensome: it requires considerable attention to nutrition and medical treatment, and can hinder social activities. Support from psychologists, dietitians, and peer support groups can help with adjustments and emotional stress.

ProveniIncluded in official guidelines, or approved by EMA or FDA

---

_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._

↑ Back to top

Sources used

Above each source is one sentence describing what the research is about, so you don't have to rely on an English technical title. Find more studies on Short Bowel Syndrome at publications and studies.

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.